MyFinsight
Home
Blog
About
Due from
subsidiaries
$478,571
Intangible assets, net
(note 6)
$158,898
(27.02%↑ Y/Y)
Cash and cash
equivalents
$83,586
(730.71%↑ Y/Y)
Loan receivable
$60,095
Prepaid expenses
$10,600
(4.43%↑ Y/Y)
Total other assets
$637,469
Total current assets
$154,281
(663.31%↑ Y/Y)
Total assets
$791,750
(444.88%↑ Y/Y)
Accumulated deficit
-$6,420,060
(-39.38%↓ Y/Y)
Total liabilities and
stockholders deficit
$791,750
(444.88%↑ Y/Y)
Total stockholders
deficit
-$3,222,566
(-61.82%↓ Y/Y)
Additional paid in capital
$3,017,027
(23.12%↑ Y/Y)
Common stock, 0.001 par
value, 500,000,000...
$153,917
(11.93%↑ Y/Y)
Preferred stock series a,
0.001 par value, 5,000...
$15,250
(0.00%↑ Y/Y)
Preferred stock, 0.001 par
value, 20,000,000...
$11,300
(0.00%↑ Y/Y)
Total liabilities
$4,014,316
(87.87%↑ Y/Y)
Total current
liabilities
$4,014,316
(87.87%↑ Y/Y)
Accounts payable
$1,729,921
(53.90%↑ Y/Y)
Loan payable -
related parties (note 7)
$802,972
(27.07%↑ Y/Y)
Loan payable (note 8)
$756,285
(740.32%↑ Y/Y)
Convertible notes payable
(note 8)
$725,138
(149.35%↑ Y/Y)
Back
Back
Balance Sheet
AVAI BIO, INC. (AVAI)
AVAI BIO, INC. (AVAI)
source: myfinsight.com